Demystifying Cancer Immunotherapy for Lay Audiences Article Swipe
Kiara Ellis
,
Christopher A. Pennell
·
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.3389/fimmu.2019.02488
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.3389/fimmu.2019.02488
Immunotherapy is now mainstream. Advertisements are ubiquitous in print and visual media for immune based-therapies for various conditions and diseases. Smaller companies that develop novel immunotherapies are often quickly acquired by larger companies. More and more clinical trials are open for immune-based therapies, particularly for immune checkpoint blockades. As such, immunologists need to engage the public in conversations about the strengths and limitations of immunotherapy, and the necessity of research in propelling the field further. In this article, we discuss approaches we have taken to convey key concepts in immunology and cancer immunotherapy to non-scientists and health care professionals without expertise in immunology. Although the devil is always in the details, basic concepts in immunology and immunotherapy can be readily conveyed using stories and analogies, some of which we present here.
Related Topics
Concepts
Immunotherapy
Cancer immunotherapy
Medicine
Mainstream
Clinical trial
Immunology
Immune system
Political science
Pathology
Law
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.3389/fimmu.2019.02488
- https://www.frontiersin.org/articles/10.3389/fimmu.2019.02488/pdf
- OA Status
- gold
- Cited By
- 4
- References
- 24
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2980705232
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2980705232Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.3389/fimmu.2019.02488Digital Object Identifier
- Title
-
Demystifying Cancer Immunotherapy for Lay AudiencesWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2019Year of publication
- Publication date
-
2019-10-18Full publication date if available
- Authors
-
Kiara Ellis, Christopher A. PennellList of authors in order
- Landing page
-
https://doi.org/10.3389/fimmu.2019.02488Publisher landing page
- PDF URL
-
https://www.frontiersin.org/articles/10.3389/fimmu.2019.02488/pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.frontiersin.org/articles/10.3389/fimmu.2019.02488/pdfDirect OA link when available
- Concepts
-
Immunotherapy, Cancer immunotherapy, Medicine, Mainstream, Clinical trial, Immunology, Immune system, Political science, Pathology, LawTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
4Total citation count in OpenAlex
- Citations by year (recent)
-
2024: 1, 2022: 1, 2021: 1, 2020: 1Per-year citation counts (last 5 years)
- References (count)
-
24Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2980705232 |
|---|---|
| doi | https://doi.org/10.3389/fimmu.2019.02488 |
| ids.doi | https://doi.org/10.3389/fimmu.2019.02488 |
| ids.mag | 2980705232 |
| ids.openalex | https://openalex.org/W2980705232 |
| fwci | 0.3766573 |
| type | article |
| title | Demystifying Cancer Immunotherapy for Lay Audiences |
| biblio.issue | |
| biblio.volume | 10 |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11491 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9997000098228455 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | CAR-T cell therapy research |
| topics[1].id | https://openalex.org/T10158 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9994999766349792 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | Cancer Immunotherapy and Biomarkers |
| topics[2].id | https://openalex.org/T10580 |
| topics[2].field.id | https://openalex.org/fields/24 |
| topics[2].field.display_name | Immunology and Microbiology |
| topics[2].score | 0.9987000226974487 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2403 |
| topics[2].subfield.display_name | Immunology |
| topics[2].display_name | Immunotherapy and Immune Responses |
| funders[0].id | https://openalex.org/F4320337351 |
| funders[0].ror | https://ror.org/040gcmg81 |
| funders[0].display_name | National Cancer Institute |
| is_xpac | False |
| apc_list.value | 2950 |
| apc_list.currency | USD |
| apc_list.value_usd | 2950 |
| apc_paid.value | 2950 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2950 |
| concepts[0].id | https://openalex.org/C2777701055 |
| concepts[0].level | 3 |
| concepts[0].score | 0.7818443775177002 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q1427096 |
| concepts[0].display_name | Immunotherapy |
| concepts[1].id | https://openalex.org/C2780674031 |
| concepts[1].level | 4 |
| concepts[1].score | 0.6173441410064697 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q2012719 |
| concepts[1].display_name | Cancer immunotherapy |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.5733611583709717 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C2777617010 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5179709196090698 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q18957 |
| concepts[3].display_name | Mainstream |
| concepts[4].id | https://openalex.org/C535046627 |
| concepts[4].level | 2 |
| concepts[4].score | 0.4707910120487213 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q30612 |
| concepts[4].display_name | Clinical trial |
| concepts[5].id | https://openalex.org/C203014093 |
| concepts[5].level | 1 |
| concepts[5].score | 0.44115662574768066 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[5].display_name | Immunology |
| concepts[6].id | https://openalex.org/C8891405 |
| concepts[6].level | 2 |
| concepts[6].score | 0.4298310875892639 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[6].display_name | Immune system |
| concepts[7].id | https://openalex.org/C17744445 |
| concepts[7].level | 0 |
| concepts[7].score | 0.12727069854736328 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q36442 |
| concepts[7].display_name | Political science |
| concepts[8].id | https://openalex.org/C142724271 |
| concepts[8].level | 1 |
| concepts[8].score | 0.10844239592552185 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[8].display_name | Pathology |
| concepts[9].id | https://openalex.org/C199539241 |
| concepts[9].level | 1 |
| concepts[9].score | 0.0 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7748 |
| concepts[9].display_name | Law |
| keywords[0].id | https://openalex.org/keywords/immunotherapy |
| keywords[0].score | 0.7818443775177002 |
| keywords[0].display_name | Immunotherapy |
| keywords[1].id | https://openalex.org/keywords/cancer-immunotherapy |
| keywords[1].score | 0.6173441410064697 |
| keywords[1].display_name | Cancer immunotherapy |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.5733611583709717 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/mainstream |
| keywords[3].score | 0.5179709196090698 |
| keywords[3].display_name | Mainstream |
| keywords[4].id | https://openalex.org/keywords/clinical-trial |
| keywords[4].score | 0.4707910120487213 |
| keywords[4].display_name | Clinical trial |
| keywords[5].id | https://openalex.org/keywords/immunology |
| keywords[5].score | 0.44115662574768066 |
| keywords[5].display_name | Immunology |
| keywords[6].id | https://openalex.org/keywords/immune-system |
| keywords[6].score | 0.4298310875892639 |
| keywords[6].display_name | Immune system |
| keywords[7].id | https://openalex.org/keywords/political-science |
| keywords[7].score | 0.12727069854736328 |
| keywords[7].display_name | Political science |
| keywords[8].id | https://openalex.org/keywords/pathology |
| keywords[8].score | 0.10844239592552185 |
| keywords[8].display_name | Pathology |
| language | en |
| locations[0].id | doi:10.3389/fimmu.2019.02488 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2595292759 |
| locations[0].source.issn | 1664-3224 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1664-3224 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Frontiers in Immunology |
| locations[0].source.host_organization | https://openalex.org/P4310320527 |
| locations[0].source.host_organization_name | Frontiers Media |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320527 |
| locations[0].source.host_organization_lineage_names | Frontiers Media |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.frontiersin.org/articles/10.3389/fimmu.2019.02488/pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Frontiers in Immunology |
| locations[0].landing_page_url | https://doi.org/10.3389/fimmu.2019.02488 |
| locations[1].id | pmh:oai:doaj.org/article:5742e224992840d2bf89c5a9607df761 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306401280 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[1].source.host_organization | |
| locations[1].source.host_organization_name | |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | article |
| locations[1].license_id | |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | Frontiers in Immunology, Vol 10 (2019) |
| locations[1].landing_page_url | https://doaj.org/article/5742e224992840d2bf89c5a9607df761 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:6813245 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | cc-by |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Front Immunol |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/6813245 |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5015444844 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Kiara Ellis |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I130238516 |
| authorships[0].affiliations[0].raw_affiliation_string | Office of Community Engagement and Education, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States |
| authorships[0].institutions[0].id | https://openalex.org/I130238516 |
| authorships[0].institutions[0].ror | https://ror.org/017zqws13 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I130238516 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | University of Minnesota |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Kiara Ellis |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Office of Community Engagement and Education, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States |
| authorships[1].author.id | https://openalex.org/A5055928297 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-2901-6554 |
| authorships[1].author.display_name | Christopher A. Pennell |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210135252 |
| authorships[1].affiliations[0].raw_affiliation_string | Center for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, United States |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I130238516 |
| authorships[1].affiliations[1].raw_affiliation_string | Office of Community Engagement and Education, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States |
| authorships[1].institutions[0].id | https://openalex.org/I130238516 |
| authorships[1].institutions[0].ror | https://ror.org/017zqws13 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I130238516 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | University of Minnesota |
| authorships[1].institutions[1].id | https://openalex.org/I4210135252 |
| authorships[1].institutions[1].ror | https://ror.org/03e1ayz78 |
| authorships[1].institutions[1].type | healthcare |
| authorships[1].institutions[1].lineage | https://openalex.org/I1309104334, https://openalex.org/I4210135252 |
| authorships[1].institutions[1].country_code | US |
| authorships[1].institutions[1].display_name | University of Minnesota Medical Center |
| authorships[1].author_position | last |
| authorships[1].raw_author_name | Christopher A. Pennell |
| authorships[1].is_corresponding | True |
| authorships[1].raw_affiliation_strings | Center for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, United States, Office of Community Engagement and Education, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.frontiersin.org/articles/10.3389/fimmu.2019.02488/pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2019-10-25T00:00:00 |
| display_name | Demystifying Cancer Immunotherapy for Lay Audiences |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11491 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9997000098228455 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | CAR-T cell therapy research |
| related_works | https://openalex.org/W3111580887, https://openalex.org/W3049036915, https://openalex.org/W4313343001, https://openalex.org/W4223914026, https://openalex.org/W3158104901, https://openalex.org/W4396582463, https://openalex.org/W2999675030, https://openalex.org/W2400599632, https://openalex.org/W2806333505, https://openalex.org/W3154696046 |
| cited_by_count | 4 |
| counts_by_year[0].year | 2024 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2022 |
| counts_by_year[1].cited_by_count | 1 |
| counts_by_year[2].year | 2021 |
| counts_by_year[2].cited_by_count | 1 |
| counts_by_year[3].year | 2020 |
| counts_by_year[3].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | doi:10.3389/fimmu.2019.02488 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2595292759 |
| best_oa_location.source.issn | 1664-3224 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1664-3224 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Frontiers in Immunology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320527 |
| best_oa_location.source.host_organization_name | Frontiers Media |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320527 |
| best_oa_location.source.host_organization_lineage_names | Frontiers Media |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.frontiersin.org/articles/10.3389/fimmu.2019.02488/pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Frontiers in Immunology |
| best_oa_location.landing_page_url | https://doi.org/10.3389/fimmu.2019.02488 |
| primary_location.id | doi:10.3389/fimmu.2019.02488 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2595292759 |
| primary_location.source.issn | 1664-3224 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1664-3224 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Frontiers in Immunology |
| primary_location.source.host_organization | https://openalex.org/P4310320527 |
| primary_location.source.host_organization_name | Frontiers Media |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320527 |
| primary_location.source.host_organization_lineage_names | Frontiers Media |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.frontiersin.org/articles/10.3389/fimmu.2019.02488/pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Frontiers in Immunology |
| primary_location.landing_page_url | https://doi.org/10.3389/fimmu.2019.02488 |
| publication_date | 2019-10-18 |
| publication_year | 2019 |
| referenced_works | https://openalex.org/W1984066971, https://openalex.org/W2067025070, https://openalex.org/W2405351537, https://openalex.org/W1996409699, https://openalex.org/W2318605753, https://openalex.org/W1970568097, https://openalex.org/W2114737175, https://openalex.org/W2023038954, https://openalex.org/W2117692326, https://openalex.org/W2114416030, https://openalex.org/W2001258296, https://openalex.org/W2162856391, https://openalex.org/W1538902372, https://openalex.org/W2094366129, https://openalex.org/W2063264144, https://openalex.org/W2912945415, https://openalex.org/W2338453174, https://openalex.org/W6713762055, https://openalex.org/W2117847125, https://openalex.org/W2151246207, https://openalex.org/W2118796952, https://openalex.org/W2004550484, https://openalex.org/W4302609765, https://openalex.org/W206701898 |
| referenced_works_count | 24 |
| abstract_inverted_index.As | 48 |
| abstract_inverted_index.In | 75 |
| abstract_inverted_index.be | 118 |
| abstract_inverted_index.by | 30 |
| abstract_inverted_index.in | 7, 56, 70, 88, 101, 108, 113 |
| abstract_inverted_index.is | 1, 106 |
| abstract_inverted_index.of | 63, 68, 126 |
| abstract_inverted_index.to | 52, 84, 93 |
| abstract_inverted_index.we | 78, 81, 128 |
| abstract_inverted_index.and | 9, 18, 34, 61, 65, 90, 95, 115, 123 |
| abstract_inverted_index.are | 5, 26, 38 |
| abstract_inverted_index.can | 117 |
| abstract_inverted_index.for | 12, 15, 40, 44 |
| abstract_inverted_index.key | 86 |
| abstract_inverted_index.now | 2 |
| abstract_inverted_index.the | 54, 59, 66, 72, 104, 109 |
| abstract_inverted_index.More | 33 |
| abstract_inverted_index.care | 97 |
| abstract_inverted_index.have | 82 |
| abstract_inverted_index.more | 35 |
| abstract_inverted_index.need | 51 |
| abstract_inverted_index.open | 39 |
| abstract_inverted_index.some | 125 |
| abstract_inverted_index.that | 22 |
| abstract_inverted_index.this | 76 |
| abstract_inverted_index.about | 58 |
| abstract_inverted_index.basic | 111 |
| abstract_inverted_index.devil | 105 |
| abstract_inverted_index.field | 73 |
| abstract_inverted_index.here. | 130 |
| abstract_inverted_index.media | 11 |
| abstract_inverted_index.novel | 24 |
| abstract_inverted_index.often | 27 |
| abstract_inverted_index.print | 8 |
| abstract_inverted_index.such, | 49 |
| abstract_inverted_index.taken | 83 |
| abstract_inverted_index.using | 121 |
| abstract_inverted_index.which | 127 |
| abstract_inverted_index.always | 107 |
| abstract_inverted_index.cancer | 91 |
| abstract_inverted_index.convey | 85 |
| abstract_inverted_index.engage | 53 |
| abstract_inverted_index.health | 96 |
| abstract_inverted_index.immune | 13, 45 |
| abstract_inverted_index.larger | 31 |
| abstract_inverted_index.public | 55 |
| abstract_inverted_index.trials | 37 |
| abstract_inverted_index.visual | 10 |
| abstract_inverted_index.Smaller | 20 |
| abstract_inverted_index.develop | 23 |
| abstract_inverted_index.discuss | 79 |
| abstract_inverted_index.present | 129 |
| abstract_inverted_index.quickly | 28 |
| abstract_inverted_index.readily | 119 |
| abstract_inverted_index.stories | 122 |
| abstract_inverted_index.various | 16 |
| abstract_inverted_index.without | 99 |
| abstract_inverted_index.Although | 103 |
| abstract_inverted_index.acquired | 29 |
| abstract_inverted_index.article, | 77 |
| abstract_inverted_index.clinical | 36 |
| abstract_inverted_index.concepts | 87, 112 |
| abstract_inverted_index.conveyed | 120 |
| abstract_inverted_index.details, | 110 |
| abstract_inverted_index.further. | 74 |
| abstract_inverted_index.research | 69 |
| abstract_inverted_index.companies | 21 |
| abstract_inverted_index.diseases. | 19 |
| abstract_inverted_index.expertise | 100 |
| abstract_inverted_index.necessity | 67 |
| abstract_inverted_index.strengths | 60 |
| abstract_inverted_index.analogies, | 124 |
| abstract_inverted_index.approaches | 80 |
| abstract_inverted_index.blockades. | 47 |
| abstract_inverted_index.checkpoint | 46 |
| abstract_inverted_index.companies. | 32 |
| abstract_inverted_index.conditions | 17 |
| abstract_inverted_index.immunology | 89, 114 |
| abstract_inverted_index.propelling | 71 |
| abstract_inverted_index.therapies, | 42 |
| abstract_inverted_index.ubiquitous | 6 |
| abstract_inverted_index.immunology. | 102 |
| abstract_inverted_index.limitations | 62 |
| abstract_inverted_index.mainstream. | 3 |
| abstract_inverted_index.immune-based | 41 |
| abstract_inverted_index.particularly | 43 |
| abstract_inverted_index.Immunotherapy | 0 |
| abstract_inverted_index.conversations | 57 |
| abstract_inverted_index.immunologists | 50 |
| abstract_inverted_index.immunotherapy | 92, 116 |
| abstract_inverted_index.professionals | 98 |
| abstract_inverted_index.Advertisements | 4 |
| abstract_inverted_index.immunotherapy, | 64 |
| abstract_inverted_index.non-scientists | 94 |
| abstract_inverted_index.based-therapies | 14 |
| abstract_inverted_index.immunotherapies | 25 |
| cited_by_percentile_year.max | 94 |
| cited_by_percentile_year.min | 89 |
| corresponding_author_ids | https://openalex.org/A5055928297 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 2 |
| corresponding_institution_ids | https://openalex.org/I130238516, https://openalex.org/I4210135252 |
| citation_normalized_percentile.value | 0.63552912 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |